[1]
Ainaputri , A.S., Kasasiah, A., Malau , J., Aprillia , C., Siboro , D.P.P., Apriyanti , E. and Nugraha , A.T. 2026. Butirat Supplementation and Epigenetic Modulation via Histon Deacetylase Inhibition in Type 2 Diabetes: A Narrative Review with Perspectives for Indonesia. Journal of Pharmaceutical and Sciences. 9, 1 (Feb. 2026), 407–422. DOI:https://doi.org/10.36490/journal-jps.com.v9i1.1301.